Indaptus Therapeutics (INDP) Financials

$1.85

$0.63 (51.64%)

As on 08-Sep-2026 16:29EDT

Market cap

$163 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

13.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	0.00	0.00	0.00	0.00
Gross Profit	--	--	0.00	0.00	0.00	0.00
Operating Expenses	14.77	19.83	15.37	16.38	14.91	7.73
Operating Profit (EBIT)	-14.77	-19.83	-15.37	-16.38	-14.91	-7.73
Other Income	--	--	--	--	--	--
Profit before Tax	-15.42	-20.85	-15.02	-15.42	-14.32	-7.71
Provision for Tax	--	--	--	-16.38	-0.59	-0.02
Profit after Tax (Net Income)	-15.42	-20.85	-15.02	-15.42	-14.32	-7.71
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-14.32	-7.71

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	11.37	3.15	3.94	12.08	24.63	35.90
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	--	0.07	1.46	0.07
Current Liabilities	0.62	6.16	3.39	2.77	3.43	4.60
Total Liabilities	12.60	9.31	7.34	14.92	28.06	40.58

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	--	--	0.72	0.93	0.82	0.19
Current Assets	11.99	9.31	6.62	14.00	27.24	40.39
Total Assets	12.60	9.31	7.34	14.92	28.06	40.58
Total Debt*	--	--	0.08	0.18	0.08	0.17
Net Current Assets	11.37	3.15	3.22	11.22	23.81	35.78

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-14.82	-12.32	-13.41	-13.08	-11.29
Cash Flow from Investing Activities	--	--	--	17.14	-16.43	0.45
Cash from Financing Activities	--	17.54	4.75	--	0.36	48.34
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-6.97	-9.62	-1.61	-1.84	-1.73	-1.89
Cash EPS ($)	--	-9.62	-1.61	-1.84	-1.73	-1.88
Adjusted Book Value ($)	--	1.45	0.42	1.44	2.98	8.78
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-6.84	-1.32	-1.60	-1.58	-2.76
Free Cash Flow per Share ($)	--	-6.84	-1.32	-1.60	-1.60	-2.76

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-580.70	-184.54	-83.45	-47.13	-42.84
ROE (%)	-212.38	-587.59	-187.52	-84.04	-47.32	-43.25
ROA (%)	-110.34	-250.45	-134.95	-71.76	-41.73	-36.41
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	--	--	2.60	-7.68	-85.74	-114.25
Net Profit Growth (%)	9.07	-38.79	2.60	-7.68	-85.74	-115.15
EPS Growth (%)	-223.45	-4.99	0.13	-0.06	0.08	-1.84
Book Value Growth (%)	133.72	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.30	-0.52	-0.96	-0.84	-3.02
Price / Book Value	13.24	2.00	2.00	1.22	0.49	0.65
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	1.03	0.11	-0.14	-0.10	1.00	2.03
Close Price ($)	3.00	2.91	23.58	49.28	40.60	159.60
High Price ($)	13.40	47.60	86.80	114.24	198.80	1,030.40
Low Price ($)	0.92	1.65	22.68	38.92	35.00	136.64
Market Cap ($ Cr)	162.56	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	--	0.02	0.01	0.00	0.00
Short term debt to equity ratio	--	--	0.02	0.01	0.00	0.00
Current Ratio	19.48	1.51	1.95	5.05	7.94	8.77
Quick Ratio	19.48	--	--	--	--	--
Interest Coverage	--	--	--	--	-24.35	-435.13

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	416,492.59	310,678.69	411,815.99	363,657.14
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.